Pharmaceutical Technology Europe 2008 Media Planner

print | online | digital interactive | email | directories Unrivalled circulation It’s a fact, Pharmaceutical Technology Europe has the largest independently audited circulation of European subscribers involved in pharmaceutical manufacturing 192 Publication % MORE SUBSCRIBERS than the next largest audited competitor Audit Bureau BPA* BPA* ABC ABC Not audited European Circulation 18000 5130 6156 2990 12134 Job functions1 Research & Development 22.8% Manufacturing (production, processing, packaging) 21.3% Quality Control/ Quality Assurance/ Validation 20.3% Corporate/ General Management 16.0% Purchasing 5.0% Process Development 4.2% Regulatory Affairs 3.8% Other Functions* 2.8% Project/Facility Engineering 2.1% IT (software, systems) 1.7% * Includes Marketing/Sales, Consulting & Production/Manufacturing Pharmaceutical Technology Europe Pharmaceutical Engineering Manufacturing Chemist European Pharmaceutical Review European Pharmaceutical Manufacturer *BPA Worldwide Audit Statement, June 2007 ABC Statement, Jan-Dec 2006 The UK circulation is 2990. Other countries is 9,000 but not stated if this includes any other European countries. Circulation figures are not independently audited. The figures are the Publisher’s own statement, August 2007. Correct at time of going to press. Subscribers across Europe1 Western Europe 66% UK 20.2% Northern Europe 9.1% Central & Eastern Europe 3.8% Southern Europe 0.9% Recipients by country1 Country Number of subscribers Austria 252 Belgium 991 Central & Eastern Europe* 682 Denmark 753 Finland 182 France 2370 Germany 2728 Greece 120 Ireland 1144 Italy 1301 Norway 162 Other 68 Portugal 200 Spain 1066 Sweden 527 Switzerland 893 The Netherlands 919 UK 3642 Percentages based on 18,000 total qualified circulation The PTE circulation is 100% requested Recipients’ primary business1 Pharmaceutical 55% Biopharmaceutical/ Manufacturing 14.3% Drug Delivery & Medical Products/ Devices 8.3% Contract Services/ Outsourcing 5.8% API/Raw Materials/Ingredients Manufacturer/Speciality Chemicals 5.5% Clinical Diagnosis/ Biodiagnostics, Nutraceutical, Diagnostics, Biotech Research, Bulk Products & Raw Material Producer, Consultancy to Pharmaceutical Industry & Other 4.2% University 3.3% Plant Design & Construction/ Engineering Services 2.4% Government 1.2% Percentages based on 18,000 total qualified circulation * Croatia, Czech Republic, Hungary, Latvia, Lithuania, Poland, Romania, Serbia & Montenegro, Slovakia & Slovenia Cyprus, Iceland, Luxembourg, Malta, Monaco & San Marino 100% Guarantee of Circulation Accuracy & Excellence Undergoing the most rigorous scrutiny every year by BPA Worldwide (the international media auditing organisation), the PTE circulation is accurate and up-to-date enabling advertisers to have total confidence in PTE. This independent verification of subscribers is a ‘stamp of excellence’ providing 100% assurance that the magazine is delivered exactly to whom we say it is. All recipients have subscribed or re-subscribed within the last 2 years1, so you can be assured that subscribers really are still active within the industry. 1 BPA Worldwide Circulation Statement, June 2007

Table of Contents Feed for the Digital Edition of Pharmaceutical Technology Europe 2008 Media Planner

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.